Showing 1 to 3 of 3 results


US Removes Thimerosal from All Flu Vaccines
The US Department of Health and Human Services adopted a recommendation to remove the mercury-based preservative thimerosal from all US influenza vaccines, following a 5-1 vote by a newly appointed CDC advisory committee, despite limited evidence of harm and concerns about reduced vaccine access.
US Removes Thimerosal from All Flu Vaccines
The US Department of Health and Human Services adopted a recommendation to remove the mercury-based preservative thimerosal from all US influenza vaccines, following a 5-1 vote by a newly appointed CDC advisory committee, despite limited evidence of harm and concerns about reduced vaccine access.
Progress
52% Bias Score


US H5N1 Outbreak Prompts State of Emergency, Fuels Vaccine Research
Over 60 human H5N1 infections and 123 million poultry infections across the US have prompted a state of emergency in California and highlight the need for new vaccine technologies to combat potential human-to-human transmission.
US H5N1 Outbreak Prompts State of Emergency, Fuels Vaccine Research
Over 60 human H5N1 infections and 123 million poultry infections across the US have prompted a state of emergency in California and highlight the need for new vaccine technologies to combat potential human-to-human transmission.
Progress
28% Bias Score

Trump Administration Cancels $766 Million Moderna Flu Vaccine Contract
The Trump administration cancelled two Moderna contracts worth $766 million for H5N1 bird flu vaccines following positive trial results, citing insufficient testing of mRNA technology, despite a prior US bird flu outbreak resulting in one death.

Trump Administration Cancels $766 Million Moderna Flu Vaccine Contract
The Trump administration cancelled two Moderna contracts worth $766 million for H5N1 bird flu vaccines following positive trial results, citing insufficient testing of mRNA technology, despite a prior US bird flu outbreak resulting in one death.
Progress
44% Bias Score
Showing 1 to 3 of 3 results